Search results
Results from the WOW.Com Content Network
St. Jude Medical was founded in 1976 to further develop bi-leaflet artificial heart valves, which were originally created in 1972 at the University of Minnesota. [4] [5] St. Jude Medical's bi-leaflet valve was developed in large part by Dr. Demetre Nicoloff of the University of Minnesota and St. Jude Medical employee Don Hanson.
Rank Year Purchaser Target Value (in billions USD) Value (adjusted for inflation) 1 2015 Pfizer: Allergan, plc: 160 212 In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($212 billion, adjusted for inflation).
St Jude Medical: 25.0 — 30.5: 32.8 — 40 [314] 65 2019: Viacom: CBS Corporation: 25.0 30.7 [315] 66 2019 Pfizer (Upjohn Off-Patent Medicine Division) Mylan: 25.0 ...
St. Jude Medical Signs Equity Investment and Option to Purchase Agreement with Spinal Modulation Agreement provides St. Jude Medical immediate international distribution rights for the Axium ...
What: Shares of medical device maker St. Jude. Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're ...
St. Jude Medical Reports Third Quarter 2012 Results and Announces the Authorization of a $300 Million Stock Repurchase Program ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYS: STJ ...
St. Jude Medical (NYS: STJ) carries $3.9 billion of goodwill and other intangibles on its balance sheet. Sometimes goodwill, especially when it's excessive, can foreshadow problems down the road.
Another piece of bad news has come out for St. Jude Medical (NYS: STJ) regarding an FDA report on defibrillator lead Durata, bringing shares down 12%. In this video, Motley Fool health-care ...